All-Star
Genetics
About Us
Big League Genetics is an Alberta-based cannabis company specializing in pheno-hunted, rigorously tested cultivars. Since 2021, our dedicated, expert team has scouted hundreds of genetics, backed by in-house tissue culture and a commitment to clean, consistent production. We work with partners in international markets to supply premium flower and genetics to licensed producers around the world.
Scouting For
Winning Genetics
Our in-house pheno hunting program identifies and selects only the strongest genetics, helping you build a reliable, high-performing portfolio that drives success.
Preserving our
MVPs in Play
In partnership with 3 Rivers Biotech, we use advanced tissue culture to preserve elite cuts, reduce risk, and deliver cleaner, more uniform crops.
Rooted in Trust,
Backed by Science
We don’t just claim clean genetics, we prove it. Through extensive screening and in-house tissue culture, we stand behind every plant we release, giving you confidence in what you’re putting in your rooms.
Step Up to The Plate
Unlock access to our premium genetic library. Pheno-hunted in house, multi-screened, and production-tested by our own cultivation team.
Click below to join the big leagues!
Step Up to The Plate
Unlock access to our premium genetic library. Pheno-hunted in house, multi-screened, and production-tested by our own cultivation team.
Click below to join the big leagues!
Articles
Articles
Big League Genetics Licenses 3R Biotech’s Clean Cannabis Tissue Culture Platform
Big League Genetics has exported cannabis genetics to German producer DEMECAN, marking a key move following Germany’s legalization of recreational cannabis. The partnership aims to advance genetic innovation and supply. DEMECAN sees this as a pivotal step in leveraging legalization to expand production, research, and direct pharmacy access.
This Canadian Nursery Is Exporting New Cannabis Strains To German Cannabis Producer Demecan
Big League Genetics has exported cannabis genetics to German producer DEMECAN, marking a key move following Germany’s legalization of recreational cannabis. The partnership aims to advance genetic innovation and supply. DEMECAN sees this as a pivotal step in leveraging legalization to expand production, research, and direct pharmacy access.
